文献速递心境障碍

重性抑郁障碍中的线粒体-炎症交互作用:分子机制与治疗启示

Mitochondrial-inflammation crosstalk in major depressive disorder: molecular mechanisms and therapeutic implications.
PubMed 文献 · Mol Psychiatry · 2026-07-03

本文综述重性抑郁障碍(MDD)中线粒体功能障碍与神经炎症的双向交互作用。线粒体损伤相关分子模式及活性氧激活先天免疫信号,炎症又损害线粒体完整性,形成自我强化循环,参与疾病发生、进展与临床异质性。传统抗抑郁药逐渐恢复线粒体功能并抑制氧化炎症应激,氯胺酮等速效药则急性诱导代谢重编程与线粒体自噬。

要点

  • 线粒体功能障碍与炎症在MDD中形成双向自我强化循环。
  • 传统抗抑郁药逐渐恢复线粒体功能并抑制氧化炎症应激。
  • 氯胺酮急性诱导代谢重编程与线粒体自噬促快速功能恢复。

核心结论

  • 线粒体-炎症交互作用可能是MDD发病、进展及临床异质性的重要机制。
  • 靶向线粒体调节是新型抗抑郁策略的有前景方向。

研究设计与样本

  • 综述整合临床前与临床研究证据, delineate MDD中线粒体-炎症交互作用。

主要发现

  • 线粒体DNA异常、生物能量学受损、质量控制紊乱及氧化还原失衡是MDD核心病理特征。
  • 线粒体来源损伤相关分子模式及过量活性氧激活先天免疫信号,炎症挑战反过来损害线粒体完整性。
  • 传统抗抑郁药逐渐恢复线粒体功能并抑制氧化与炎症应激,氯胺酮等速效药急性诱导代谢重编程与线粒体自噬。

临床怎么用

  • 线粒体调节可作为新型抗抑郁策略的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite its high prevalence, the precise mechanisms underlying major depressive disorder (MDD) remain incompletely understood. Growing evidence identifies mitochondrial dysfunction, including abnormalities in mitochondrial DNA, impaired bioenergetics, disrupted quality control, and redox imbalance, as a central pathological feature of MDD. Beyond deficits in energy production, mitochondria function as upstream regulators of neuroinflammation. Mitochondria derived damage associated molecular patterns and excessive reactive oxygen species activate innate immune signaling, while inflammatory challenges in turn compromise mitochondrial integrity. This bidirectional and self-reinforcing interaction between mitochondrial dysfunction and inflammation may contribute to disease onset, progression, and clinical heterogeneity. Preclinical and clinical studies indicate that conventional antidepressants gradually restore mitochondrial function while suppressing oxidative and inflammatory stress, whereas rapid-acting agents such as ketamine induce acute metabolic reprogramming and mitophagy, enabling swift functional recovery. Mechanistically distinct interventions, including mitochondria targeted antioxidants, metabolic modulators, and psychedelic compounds, further highlight the therapeutic potential of targeting mitochondrial pathways. By integrating current evidence, this review delineates mitochondrial-inflammation crosstalk in MDD and supports mitochondrial regulation as a promising target for novel antidepressant strategies.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Wang Y, Li JT, Zhu LL, et al. Mitochondrial-inflammation crosstalk in major depressive disorder: molecular mechanisms and therapeutic implications. Mol Psychiatry. 2026. PMID: 42399415. doi:10.1038/s41380-026-03732-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。